Brief: Genprex Inc Regains Compliance With NASDAQ Minimum Bid Price Requirement
05/11/2024 20:14
Nov 5 (Reuters) - Genprex Inc GNPX.O :
* GENPREX INC: REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID
PRICE
REQUIREMENT
Source text: ID:n0001437749-24-033217
Further company coverage: GNPX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genprex
See all newsBrief: Genprex Announces Collaboration With Roche Diagnostics For Biomarker Assay Validation Studies
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Genprex Announces Ip Australia's Intent To Grant Patent For Reqorsa® Gene Therapy